Atlas FDA

ACCESS HYBRITECH PSA REAGENTS ON THE ACCESS IMMUNOASSAY SYSTEMS

FDA premarket approval P850048/S033 · decided 2013-06-07

Approval details

PMA number
P850048
Supplement
S033
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
ACCESS HYBRITECH PSA REAGENTS ON THE ACCESS IMMUNOASSAY SYSTEMS
Generic name
Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer
Applicant
Beckman Coulter, Inc.
Date received
2013-03-29
Decision date
2013-06-07
Days to decision
70 days
Decision code
APPR
Product code
MTF
Advisory committee
Immunology
Expedited review
No
Location
Brea, CA
Statement
APPROVAL FOR MODIFICATION OF A SAMPLE PROBE USED IN THE UNICEL DXI600, 800 AND THE UNICEL DXC 660I, 680I, 860I, AND 880I.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Access BNP II (K252169)Beckman Coulter, Inc.2026-03-24
Access anti-HBc IgM (K254059)Beckman Coulter, Inc.2026-03-13
Access anti-HBc Total (K253687)Beckman Coulter, Inc.2026-02-19
Access anti-HAV IgM (K251995)Beckman Coulter, Inc.2026-01-27
Access Rubella IgG (K250588)Beckman Coulter, Inc.2025-11-17
iQ200 Series (K252580)Beckman Coulter, Inc.2025-09-10
Access anti-HAV (K243846)Beckman Coulter, Inc.2025-09-09
MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL) (MicroScan) (K243804)Beckman Coulter, Inc.2025-08-20